New glioblastoma vaccine shows promising results in phase Ib clinical trial
A new vaccine for glioblastoma brain cancer suspends tumor growth and is well tolerated by patients, according to the results of an early phase clinical trial.
Go to Source
Author: http://http://neurosciencenews.com/ Post date: 2019-04-01 00:00:28 Category: cancer Tag: brain Post ID: 6517
Author: http://http://neurosciencenews.com/ Post date: 2019-04-01 00:00:28 Category: cancer Tag: brain Post ID: 6517